UNDERSTANDING MECHANISMS THAT BLOCK GRPR-MEDIATED CHRONIC ITCH

了解阻止 GRPR 介导的慢性瘙痒的机制

• 批准号: 9128732
• 负责人: ZHOUFENG CHEN
• 金额: $ 35.16万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-09-01 至 2020-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9128732
• 关键词: Acute; Adverse effects; Antihistamines; Attenuated; Behavioral; Biochemical; Bombesin Receptor; Calcium; Cells; Clinical; Co-Immunoprecipitations; Complex; Development; Disease; Drug Targeting; Electrophysiology (science); Fluorescence Resonance Energy Transfer; Foundations; Future; G alpha q Protein; GRP gene; Genetic Models; Goals; Health; Image; Immune system; Label; Laboratories; Mediating; Medical; Membrane; Modeling; Molecular; Mus; Nervous system structure; Neurons; Opioid Receptor; Pattern; Phosphorylation; Phosphorylation Site; Physiological; Preparation; Process; Protein Isoforms; Proteins; Pruritus; Receptor Activation; Receptor Cross-Talk; Receptor Signaling; Resistance; Role; Series; Signal Transduction; Signaling Molecule; Skin; Small Interfering RNA; Solid; Spinal Cord; Stimulus; Techniques; Testing; Therapeutic; Work; base; behavior test; behavioral response; chronic itch; combinatorial; desensitization; design; drug discovery; effective therapy; imaging genetics; insight; interdisciplinary approach; knock-down; novel; novel therapeutics; patch clamp; programs; receptor; receptor coupling; receptor function; response; sensor; tool; transmission process

 DESCRIPTION (provided by applicant) Chronic itch is a presenting sign in numerous diseases associated with the skin, immune and nervous systems. Chronic itch is largely resistant to conventional antihistamines, and few effective therapies are available. In order to develop novel therapeutics against chronic itch, there is a pressing need for identification of itc-specific signaling mechanisms involved. Activation of kappa opioid receptor (KOR) can inhibit chronic itch. However, KOR activation is associated with several side effects that might have hindered its use as therapeutics. We recently found that gastrin-releasing peptide receptor (GRPR) is an important receptor for the development of chronic itch, and KOR activation attenuates itch by inhibiting GRPR function. Aim 1 is to determine whether KOR inhibits itch by a blockade of GRPR function. Aim 2 is to examine the role of PKC in KOR activation-mediated inhibition. Aim 3 is to determine whether KOR activation inhibits itch via KOR-GRPR heteromerization. The proposed studies are highly translational because it will provide mechanistic insights into KOR-mediated inhibition of chronic itch and will significantly expand the pool of the targets that may be explored for future KOR-GRPR-based anti-pruritus drug discovery program.

 描述（由申请人提供）慢性瘙痒是与皮肤、免疫和神经系统相关的许多疾病的表现体征。慢性瘙痒在很大程度上对传统抗组胺药具有耐药性，并且几乎没有有效的治疗方法。为了开发针对慢性瘙痒的新疗法，迫切需要鉴定所涉及的itc特异性信号传导机制。κ阿片受体（KOR）的激活可抑制慢性瘙痒。然而，KOR激活与可能阻碍其作为治疗剂的几种副作用有关。我们最近发现，胃泌素释放肽受体（GRPR）是慢性瘙痒发生的重要受体，KOR激活通过抑制GRPR功能减轻瘙痒。目的1是确定KOR是否通过阻断GRPR功能来抑制瘙痒。目的二是研究PKC在KOR激活介导的抑制中的作用。目的3是确定KOR激活是否通过KOR-GRPR异聚化抑制瘙痒。拟议的研究是高度翻译的，因为它将提供对KOR介导的慢性瘙痒抑制的机制见解，并将显着扩大未来基于KOR-GRPR的止痒药物发现计划可能探索的靶标库。